Rockwell Medical Technologies (RIMT) Triferic Sales Not Material Enough To Even Disclose, Brean Capital Notes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rebounds after Fed's first rate hike in years as oil, Treasury yields dip
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- Paradium AI (PAAI) Halted, News Pending
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Rockwell Medical (RMTI) Signs Triferic Supply Contract with Top Provider, Oppenheimer Notes
November 10, 2015 7:42 AM ESTOppenheimer analyst Ling Wang reiterated an Outperform rating and $26 price target on Rockwell Medical Technologies (NASDAQ: RMTI) following the company Q3 updated. The analyst notes the company singed a signed a supply contract with one of the top four dialysis providers for Triferic, although... More
Rockwell Medical Technologies (RMTI) Misses Q3 EPS by 3c
November 9, 2015 4:58 PM ESTRockwell Medical Technologies (NASDAQ: RMTI) reported Q3 EPS of ($0.05), $0.03 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $14.4 million versus the consensus estimate of $14.93 million.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
... More